|
2015 Conference Publication Discovery of novel cyclic peptides which exhibit glucagon-like peptide-1 (GLP-1) receptor agonismLimberakis, Chris, Aspnes, Gary, Derksen, David, Edmonds, David, Eng, Heather, Fairlie, David, Goetz, Gilles, Gopalsamy, Ariamala, Griffith, David, Hill, Timothy, Huy Hoang, , Kalgutkar, Amit, Kok, W., Liras, Spiros, Mascitti, Vincent, Mathiowetz, Alan, Mitchell, Justin, Piotrowski, David, Price, David, Rotter, Charles, Ruggeri, Roger, Song, Kun, Stanton, Robert, Suen, Jacky and Withka, Jane (2015). Discovery of novel cyclic peptides which exhibit glucagon-like peptide-1 (GLP-1) receptor agonism. WASHINGTON: AMER CHEMICAL SOC. |
|
2015 Conference Publication Cyclic penta- and hexa leucine peptides without N-methylation are orally absorbedKok, Woan Mei, Hill, Timothy A., Lohman, Rink-Jan, Hoang, Huy N., Nielsen, Daniel S., Scully, Conor G., Schroeder, Christina I., Colless, Barbara, Bernhardt, Paul V., Edmonds, David, Griffith, David, Rotter, Charles, Ruggeri, Roger, Price, David, Liras, Spiros, Craik, David and Fairlie, David (2015). Cyclic penta- and hexa leucine peptides without N-methylation are orally absorbed. American Chemical Society Meeting, x, 2015. Washington, DC United States: American Chemical Society. |
|
2012 Conference Publication Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cellsStehn, J. R., Haass, N. K., Bonello, T., Desouza, M., Kottyan, G., Treutlein, H., Zeng, J., Nascimento, P. R., Butler, T., Allanson, M., Fath, T., Hill, T. A., McCluskey, A., Schevzov, G., Palmer, S., Hardeman, E. C., Winlaw, D., Reeve, V. E., Dixon, I., Weninger, W., Cripe, T. P. and Gunning, P. (2012). Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells. 39th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Marburg Germany, Mar 01-03, 2012. WILEY-BLACKWELL. |
